Liquid biopsy for soft tissue sarcoma
Part of Cancer clinical trials.
This study checks if a blood test can detect DNA from soft tissue sarcomas. The goal is to see if circulating tumor DNA can help doctors monitor the disease and plan treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a type of soft tissue sarcoma called liposarcoma, leiomyosarcoma, or undifferentiated pleomorphic sarcoma.
- Your tumor must be in an arm, leg, or behind the belly (retroperitoneal).
- Your doctor has recommended radiation and surgery to remove the tumor.
- You are at least 18 years old.
- You are generally well enough to walk and take care of yourself.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial looks at how two test approaches (an MRI-based scan and blood tests) work in people with a larger, grade 2 or 3 soft tissue sarcoma. It may help researchers learn better ways to measure the disease and guide care.
This study looks at immune system “fingerprints” using tumor tissue from people with rare soft tissue sarcoma. It may help researchers understand what drives these cancers and guide future treatments.
This trial compares CT scans to chest X-rays to monitor for lung cancer spread after surgery to remove soft tissue sarcoma. If you are at high risk of the sarcoma returning in your lungs, this study helps see which imaging method works better.
This study is looking at genetic risk factors in people with retroperitoneal liposarcoma who are having surgery to remove the tumor. The goal is to understand how genes affect the disease and possibly guide future treatments.
This study is testing a new blood test that looks for circulating tumor cells in your blood. The goal is to see if this test can help doctors make better treatment decisions for soft tissue sarcoma, potentially improving how the disease is managed.
This study uses a simple blood test (liquid biopsy) to look for tiny pieces of tumor DNA in people with sarcoma. It may help doctors learn more about the disease and guide treatment decisions, whether you are just diagnosed, being treated, or have finished treatment recently.
Hear when a new Soft Tissue Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.